Phase II Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma
What is the purpose of this trial?
Phase II trial of nivolumab in 120 treatment naïve patients with ccRCC
- Trial withHoosier Cancer Research Network, Inc
- Start Date05/09/2019
- End Date01/31/2020
- Last Updated05/13/2019
- Study HIC#2000022534